USFDA grants Breakthrough Therapy designation to Sanofi tolebrutinib for non-relapsing secondary progressive multiple sclerosis Ruchika Sharma13 Dec 2024 3:53 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib...
Two Sanofi combination vaccine candidates for prevention of influenza, COVID gets USFDA Fast Track designation Ruchika Sharma11 Dec 2024 12:25 PM ISTParis: The US Food and Drug Administration (USFDA) has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent...
Sanofi, Regeneron Dupixent sBLA accepted for USFDA review for chronic spontaneous urticaria Ruchika Sharma17 Nov 2024 4:15 PM ISTParis: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the...
Sarclisa recommended for EU approval by CHMP to treat transplant-ineligible newly diagnosed multiple myeloma: Sanofi Ruchika Sharma17 Nov 2024 4:00 PM ISTParis: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) has adopted a...
Sanofi, Regeneron Dupixent approved in EU for young children with eosinophilic esophagitis Ruchika Sharma7 Nov 2024 3:55 PM ISTParis: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in...
Sanofi, Regeneron get USFDA nod for Dupixent for COPD Ruchika Sharma29 Sept 2024 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment...
USFDA nod to Sanofi Sarclisa in combo with bortezomib, lenalidomide, dexamethasone for newly diagnosed multiple myeloma not eligible for transpant Ruchika Sharma21 Sept 2024 2:25 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Sarclisa (isatuximab) in combination with bortezomib,...
Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India Ruchika Sharma1 Aug 2024 5:30 PM ISTDrugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...
Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement Ruchika Sharma31 July 2024 4:02 PM ISTSanofi-owned biotech company Genzyme has initiated a lawsuit against competitor Sarepta Therapeutics in Delaware federal court, accusing the firm of...
Sanofi initiates voluntary recall of Allegra, Combiflam suspensions in India over contamination in some batches Ruchika Sharma23 July 2024 11:30 AM ISTFrench Multinational Pharmaceutical Company Sanofi is voluntarily initiating a precautionary recall of Allegra Suspension syrup...
Dupixent approved in EU as targeted therapy for COPD: Sanofi, Regeneron Pharma Ruchika Sharma3 July 2024 2:00 PM ISTParis: Sanofi and Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has approved Dupixent (dupilumab) as...
Sanofi plans up to USD 1.6 billion investment in Germany: Handelsblatt Ruchika Sharma2 July 2024 2:50 PM ISTFrankfurt: French pharmaceutical company, Sanofi, is close to deciding on an investment ranging between 1.3 billion euros and 1.5 billion euros...
